Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?
Glioblastoma is the most common form of high-grade glioma in adults and has a poor survival rate with very limited treatment options. There have been no significant advancements in glioblastoma treatment in over 30 years. Epidermal growth factor receptor is upregulated in most glioblastoma tumours a...
Main Authors: | Brittany Dewdney, Lauren Ursich, Emily V. Fletcher, Terrance G. Johns |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/23/5932 |
Similar Items
-
Potassium Ion Channels in Malignant Central Nervous System Cancers
by: Yasmin Boyle, et al.
Published: (2022-09-01) -
Design of Anticancer 2,4-Diaminopyrimidines as Novel Anoctamin 1 (ANO1) Ion Channel Blockers
by: Taewoo Kim, et al.
Published: (2020-11-01) -
Store-Operated Calcium Channels Control Proliferation and Self-Renewal of Cancer Stem Cells from Glioblastoma
by: Elodie Terrié, et al.
Published: (2021-07-01) -
Influence of Anoctamin-4 and -9 on ADAM10 and ADAM17 Sheddase Function
by: Sinje Leitzke, et al.
Published: (2022-01-01) -
Finding the Right Way to Target EGFR in Glioblastomas; Lessons from Lung Adenocarcinomas
by: Ya Gao, et al.
Published: (2018-12-01)